Abstract
The recent approval of a rotavirus vaccine in Mexico motivates this study on the potential impact of the use of such a vaccine on rotavirus prevention and control. An age-structured model that describes the rotavirus transmission dynamics of infections is introduced. Conditions that guarantee the local and global stability analysis of the disease-free steady state distribution as well as the existence of an endemic steady state distribution are established. The impact of maternal antibodies on the implementation of vaccine is evaluated. Model results are used to identify optimal age-dependent vaccination strategies. A convergent numerical scheme for the model is introduced but not implemented. This paper is dedicated to Prof. K. P. Hadeler, who continues to push the frontier of knowledge in mathematical biology.
Article PDF
Similar content being viewed by others
References
Anguelov R., Lubuma J.M.-S. (2001) Contributions to the mathematics of the nonstandard finite difference method and applications. Numer. Methods Part. Diff. Eq. 17(5): 518–543
Bernstein D.I., Sander D.S., Smith V.E., Schiff G.M., Ward RL. (1991) Protection from rotavirus reinfection: 2-year prospective study. J. Infect. Dis. 164(2): 277–283
Bishop R.F., Davidson G.P., Holmes I.H., Ruck B.J. (1973) Virus particles in epithelial cells of duodenal mucosa from children with viral gastroenteritis. Lancet 1, 1281–1283
Bishop R.F., Barnes G.L., Cipriani E., Lund J.S. (1983) Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N. Engl. J. Med. 309(2): 72–76
Busenberg S., Castillo-Chavez C. (1991) A general solution of the problem of mixing subpopulations, and its application to risk- and age-structure epidemic models for the spread of AIDS. IMA. J. Math. Appl. Med. Biol. 8(1): 1–29
Castillo-Chavez C., Feng Z. (1998) Global stability of an age-structure model for TB and its applications to optimal vaccination strategies. Math. Biosc. 151(2): 135–154
Clark H.F., Lawley D., Shrager D., Jean-Guillaume D., Offit P.A., Whang S.Y., Eiden J.J., Bennett P.S., Kaplan K.M., Shaw A.R. (2004) Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4. Pediatr. Infect. Dis. J. 23(3): 206–211
Cunliffe N.A., Bresee J.S., Hart C.A. (2002) Rotavirus vaccines: development, current issues and future prospects. J. Infect. 45(1): 1–9
Dennehy P.H. (2005) Rotavirus vaccines: an update. Curr. Opin. Pediatr. 17(1): 88–92
Dietz K., Schenzle D. (1985) Proportionate mixing models for age-dependent infection transmission. J. Math Biol. 22(1): 117–120
Gripenberg G., Londen S.O., Staffans O.: Volterra Integral and Functional Equations. Series: Encyclopedia of Mathematics and its Applications (No. 34). Cambridge (1990)
Hadeler K.P., Müller J.(1993) Vaccination in age-structured populations II: optimal vaccination strategies. In: Isham V., Medley G., (ed) Models for Infectious Human Diseases: Their Structure and Relation to Data. Cambridge University Press, Cambridge, pp. 102–114
Hadeler K.P., Müller J.: Optimal harvesting and optimal vaccination, (In submission)
Hardy D. (1987) Epidemiology of rotaviral infection in adults. Rev. Infect. Dis. 9, 461–469
Hochwald C., Kivela L.: Rotavirus vaccine, live, oral, tetravalent (RotaShield). Pediatr. Nurs. 25(2), 203–204, 207 (1999)
Huang W., Castillo-Chavez C.: Age-structured core groups and their impact on HIV dynamics. In: Mathematical Approaches for Emerging and Reemerging Infectious Diseases: Models, Methods and Theory, IMA, vol. 126, pp. 261–273, Springer, Berlin Heidelberg New York
Iannelli M., Milner F., Pugliese A. (1992) Analytical and numerical results for the age structured SIS epidemic model with mixed inter-intra-cohort transmission. SIAM J. Math. Anal. Publ. Soc. Indust. Appl. Math. 23, 662–688
Kapikian A.Z., Kim H.W., Wyatt R.G., Cline W.L., Arrobio J.O., Brandt C.D., Rodriguez W.J., Sack D.A., Chanock R.M., Parrott R.H. (1976) Human reovirus-like agent as the major pathogen associated with “winter” gastroenteritis in hospitalized infants and young children. N. Engl. J. Med. 294, 965–972
Kapikian A.Z., Wyatt R.G., Levine M.M. et al. (1983) Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance. J. Infect. Dis. 147, 95–106
Kribs-Zaleta C.M., Martcheva M. (2002) Vaccination strategies and backward bifurcation in an age-since-infection structured model. Math. Biosci. 177–178: 317–332
Mastretta E., Longo P., Laccisaglia A., Balbo L., Russo R., Mazzaccara A., Gianino P. (2002) Effect of lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J. Pediat. Gastroenterol. Nutr. 35(4): 527–531
Mickens R.E. (ed) (2005) Advances in the Applications of Nonstandard Finite Difference Schemes. World Scientific Publishing Company, Singapore
Nguyen T.V., Yuan L., P Azevedo M.S., Jeong K.I., Gonzalez A.M., Iosef C., Lovgren-Bengtsson K., Morein B., Lewis P., Saif L.J. (2006) Low titer maternal antibodies can both enhance and suppress B cell responses to a combined live attenuated human rotavirus and VLP-ISCOM vaccine. Vaccine 24(13): 2302–2316
Parashar U.D., Bresee J.S., Gentsch J.R., Glass R.I. (1998) Rotavirus. Emerg. Infect. Dis. 4(4): 561–570
Parashar U.D., Holman R.C., Clarke M.J., Bresee J.S., Glass R.I. (1998) Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J. Infect. Dis. 177(1): 7–13
Pérez-Schael I., Guntiñas M.J., Pérez M., Pagone V., Rojas A.M., González R., Cunto W., Hoshino Y., Kapikian A.Z. (1997) Efficacy of the Rhesus RotavirusĐBased Quadrivalent Vaccine in Infants and Young Children in Venezuela. N. Engl. J. Med. 337(17): 1181–1187
Ramos, P D, Stefanelli C C, Linhares R E C et al. (1998) The infectivity of pig rotavirus in stools. Braz. J. Vet. Res. Anim. Sci. 35(2): 00–00
Rorres C., Fair W. (1975) Optimal harvesting policy for an age-specific population. Math. Biosci. 24, 31–47
Rotavirus Vaccine Program: A path affiliate. As found at http://www.rotavirusvaccine.org/ vaccine-facts.htm
Shim E., Banks T.B., Castillo-Chavez C.: Seasonality of rotavirus infection with its vaccination. In: Gumel A. (Chief Ed.), Castillo-Chavez C., Clemence D.P. and Mickens R.E (eds.) Modeling The Dynamics of Human Diseases: Emerging Paradigms and Challenges. AMS Cotempor. Math. Ser. (to appear).
Velazquez F.R., Matson D.O., Guerrero M.L., Shults J., Calva J.J., Morrow A.L., Glass R.I., Pickering L.K., Ruiz-Palacios G.M. (2000) Serum antibody as a marker of protection against natural rotavirus infection and disease. J. Infect. Dis. 182(6): 1602–1609
Vesikari, T, Clark H.F., Offit P.A., et al.: The effect of dose and composition of a pentavalent rotavirus vaccine (RotaTeq) upon safety, efficacy, and immunogenicity in healthy infants. In: Presented at the 22nd Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID), Tampere, Finland, 26–28, (2004)
Vesikari T., Giaquinto C., Huppertz H.I. (2006) Clinical trials of rotavirus vaccines in europe. Pediatr. Infect. Dis. J. 25(1): S42–7
Ward R.L., Bernstein D.I. (1994) Protection against rotavirus disease after natural rotavirus infection. US Rotavirus Vaccine Efficacy Group. J. Infect. Dis. 169(4): 900–904
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shim, E., Feng, Z., Martcheva, M. et al. An age-structured epidemic model of rotavirus with vaccination. J. Math. Biol. 53, 719–746 (2006). https://doi.org/10.1007/s00285-006-0023-0
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00285-006-0023-0